Immunogenicity and protective efficacy of a fucoidan adjuvanted bivalent inactivated vaccine against Aeromonas hydrophila and Edwardsiella tarda infections in Nile tilapia | Synapse
March 3, 2026
Immunogenicity and protective efficacy of a fucoidan adjuvanted bivalent inactivated vaccine against Aeromonas hydrophila and Edwardsiella tarda infections in Nile tilapia
Key Points
Immunogenicity increases with fucoidan adjuvant for bivalent vaccine against infections.
Protection against both Aeromonas hydrophila and Edwardsiella tarda enhances with vaccination.
Assessment using bivalent inactivated vaccine shows robust immune response in tilapia.
Findings may support improved vaccination strategies for tilapia aquaculture, indicating need for further studies.